Status:
COMPLETED
Secondary Prevention After Coronary Bypass Surgery
Lead Sponsor:
Jeffrey Kramer, MD
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Despite immediate symptomatic success after coronary bypass surgery in patients with coronary artery disease, this effect is not sustained over time since risk factors for coronary artery disease are ...
Eligibility Criteria
Inclusion
- Subjects over the age of 18 who will undergo a CABG procedure and who have given written informed consent
Exclusion
- Subjects under the age of 18 or who are unable to give consent on their own behald
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
115 Patients enrolled
Trial Details
Trial ID
NCT00843089
Start Date
January 1 2009
End Date
June 1 2013
Last Update
July 1 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kansas Medical Center
Kansas City, Kansas, United States, 66160